MDS: Moving Beyond the Transfusion Chair
A Conversation with an MDS Expert on Achieving Transfusion Independence
Now On Demand
Choose to watch now on demand or get a replay link sent to you to watch later.
A lower-risk MDS diagnosis can feel anything but low-impact. The fatigue is real. The appointments pile up. And it can be hard to know whether you’re doing everything you could be doing. In this program, our very own Stephanie Chuang and MDS expert Dr. Mikkael Sekeres from the University of Miami Sylvester Cancer Center talk through what’s actually changed in treatment, what your test results are telling your doctor, and how to walk into your next appointment with better questions.
Program Topics:
-
Know your MDS fingerprint
-
Finding the right dose: what the latest research shows
-
Setting transfusion independence as the target
-
Current treatment options & what’s on the horizon
Thank you to Blood Cancer United for their partnership. They are the world’s leading nonprofit dedicated to curing blood cancer and improving the lives of patients and their families. With over $2 billion invested in research since 1949, they also provide free support services including their Clinical Trials Support Center and one-on-one guidance from trained oncology information specialists at no cost.
Thank you to The MDS Foundation – a global nonprofit organization dedicated to improving the lives of those impacted by myelodysplastic syndromes—a rare and often undetected blood cancer — and its related diseases. Through patient support, professional education, research, and advocacy, they empower patients, caregivers, and healthcare professionals with the knowledge and resources needed to navigate MDS with confidence.
Thank you to Geron for its support of our independent patient education program. The Patient Story retains full editorial control over all content.
Move from overwhelmed to empowered as you listen to a leading MDS expert discuss the latest in lower-risk MDS treatments, what’s coming, and what it all means for your care.